Cytosolic calcium concentration is reduced by photolysis of a nitrosyl ruthenium complex in vascular smooth muscle cells

Nitric Oxide - Biology and Chemistry

Volumn 15, Issue 3, 2006, Pages 252-258

  Lunardi, C N ^a   Cacciari, A L ^a   Silva, R S ^a   Bendhack, L M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Intracellular calcium; Light irradiation; Nitric oxide donor; Ruthenium complex; Sodium nitroprusside; Vascular smooth muscle cell

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; CALCIUM; CYANIDE; ESTER DERIVATIVE; FLUO 3; GUANYLATE CYCLASE; GUANYLATE CYCLASE INHIBITOR; IRON; METAL COMPLEX; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; POTASSIUM CHANNEL; RUTHENIUM; TETRYLAMMONIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOSOL; FLUORESCENCE; MALE; NITROSYLATION; NONHUMAN; PHOTOLYSIS; PRIORITY JOURNAL; RAT; REDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; CALCIUM; CYTOPLASM; MALE; MOLECULAR STRUCTURE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NITRIC OXIDE DONORS; NITROPRUSSIDE; PHENYLEPHRINE; PHOTOLYSIS; RATS; RATS, WISTAR; RUTHENIUM COMPOUNDS; VASOCONSTRICTOR AGENTS;

EID: 33749040489     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2006.02.001     Document Type: Article

References (38)

1. Li N., Zou A.P., Ge Z.D., Campbell W.B., and Li P.L. Effect of nitric oxide on calcium-induced calcium release in coronary arterial smooth muscle. Gen. Pharmacol. 35 (2000) 37-45
2. Dalle-Donne I., Milzani A., Giustarini D., Di Simplicio P., Colombo R., and Rossi R. S-NO-actin: S-nitrosylation kinetics and the effect on isolated vascular smooth muscle. J. Muscle Res. Cell Motil. 21 (2000) 171-181
3. 2+ entry through store-operated channels. Brain Res. 1023 (2004) 243-252
4. Costa R.S., and Assreuy J. Multiple potassium channels mediate nitric oxide-induced inhibition of rat vascular smooth muscle cell proliferation. Nitric Oxide 13 (2005) 145-151
5. Carrier G.O., Fuchs L.C., Winecoff A.P., Giulumian A.D., and White R.E. Nitrovasodilators relax mesenteric microvessels by cGMP-induced stimulation of Ca-activated K channels. Am. J. Physiol. Heart Circ. Physiol. 273 (1997) H76-H84
6. + channels in urinary bladder myocytes through a c-GMP-dependent mechanism. Eur. J. Pharmacol. 492 (2004) 13-19
7. + channels (BKCa) in smooth muscle cells isolated from the rat mesenteric artery. Br. J. Pharmacol. 124 (1998) 1131-1140
8. Bolotina V., Najibi S., Palacino J., Pagano P., and Cohen R. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368 (1994) 850-853
9. Bonaventura D., Oliveira F.S., Togniolo V., Tedesco A.C., da Silva R.S., and Bendhack L.M. A macrocyclic nitrosyl ruthenium complex is a NO donor that induces rat aorta relaxation. Nitric Oxide 10 (2004) 83-91
10. Togniolo V., Tedesco A.C., and da Silva R.S. Photo-induced nitric oxide release from chlorobis(2,2-bipyridine)nitrosylruthenium(II) in aqueous solution. Inorg. Chim. Acta 316 (2001) 7-12
11. Bordini J., Hughes D.L., Motta Neto J.D., and da Cunha C.J. Nitric oxide photorelease from ruthenium salen complexes in aqueous and organic solutions. Inorg. Chem. 41 (2002) 5410-5416
12. Patra A.K., and Mascharak P.K. A ruthenium nitrosyl that rapidly delivers NO to proteins in aqueous solution upon short exposure to UV light. Inorg. Chem. 42 (2003) 7363-7365
13. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43 (1991) 109-142
14. Moncada S., and Higgs E.A. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 9 (1995) 1319-1330
15. 2+ wave characteristics. Cell Calcium 34 (2003) 1-9
16. Sauaia M.G., Oliveira F.S., Lima R.G., Cacciari A.L., Tfouni E., and da Silva R.S. Synthesis, characterization and photochemical properties of new NO-ruthenium(II) complexes. Inorg. Chem. Commun. 8 (2005) 347-349
17. 2+ signalling mechanisms in vascular myocytes: symposium overview. Acta Physiol. Scand. 179 (2003) 339-352
18. Wong S.K., and Garbers D.L. Receptor guanylyl cyclases. J. Clin. Invest. 90 (1992) 299-305
19. Denninger J.W., and Marletta M.A. Guanylate cyclase and the NO/cGMP signaling pathway. Biochim. Biophys. Acta 1411 (1999) 334-350
20. Anderson P.G., Boerth N.J., Liu M., McNamara D.B., Cornwell T.L., and Lincoln T.M. Cyclic GMP-dependent protein kinase expression in coronary arterial smooth muscle in response to balloon catheter injury. Arterioscler Thromb. Vasc. Biol. 20 (2000) 2192-2197
21. Schlossmann J., Feil R., and Hofmann F. Signaling through NO and cGMP-dependent protein kinases. Ann. Med. 35 (2003) 21-27
22. Aitken A., Hemmings B.A., and Hofmann F. Identification of the residues on cyclic GMP-dependent protein kinase that are autophosphorylated in the presence of cyclic AMP and cyclic GMP. Biochim. Biophys. Acta 790 (1984) 219-225
23. Chu D.M., Francis S.H., Thomas J.W., Maksymovitch E.A., Fosler M., and Corbin J.D. Activation by autophosphorylation or cGMP binding produces a similar apparent conformational change in cGMP-dependent protein kinase. J. Biol. Chem. 273 (1998) 14649-14656
24. 2+ levels in NO-induced inhibition of rat aortic smooth muscle cell motility. Am. J. Physiol. Heart Circ. Physiol. 288 (2005) H1859-H1866
25. Lincoln T.M., Dey N., and Sellak H. Invited review: cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression. J. Appl. Physiol. 91 (2001) 1421-1430
26. Si J.Q., Zhao H., Yang Y., Jiang Z.G., and Nuttall A.L. Nitric oxide induces hyperpolarization by opening ATP-sensitive K(+) channels in guinea pig spiral modiolar artery. Heart Res. 171 (2002) 167-176
27. Feelisch M. The use of nitric oxide donors in pharmacological studies. Naunyn Schmiedebergs Arch. Pharmacol. 358 (1998) 113-122
28. Feelisch M. Nitroxyl gets to the heart of the matter. Proc. Natl. Acad. Sci. USA 100 (2003) 4978-4980
29. Paolocci N., Katori T., Champion H.C., St. John M.E., Miranda K.M., Fukuto J.M., Wink D.A., and Kass D.A. Positive inotropic and lusitropic effects of HNO/NO-in failing hearts: independence from beta-adrenergic signaling. Proc. Natl. Acad. Sci. USA 100 (2003) 5537-5542
30. Ignarro L.J., Napoli C., and Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ. Res. 90 (2002) 21-28
31. Gruetter C.A., Barry B.K., McNamara D.B., Gruetter D.Y., Kadowitz P.J., and Ignarro L. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. J. Cyclic. Nucleotide Res. 5 (1979) 211-224
32. Ignarro L.J., Cirino G., Casini A., and Napoli C. Nitric oxide as a signaling molecule in the vascular system: an overview. J. Cardiovasc. Pharmacol. 34 (1999) 879-886
33. Gomes E.R., Almeida R.D., Carvalho A.P., and Duarte C.B. Nitric oxide modulates tumor cell death induced by photodynamic therapy through a cGMP-dependent mechanism. Photochem. Photobiol. 76 (2002) 423-430
34. Henderson B.W., Sitnik-Busch T.M., and Vaughan L.A. Potentiation of photodynamic therapy antitumor activity in mice by nitric oxide synthase inhibition is fluence rate dependent. Photochem. Photobiol. 70 (1999) 64-71
35. Ahmad N., and Mukhtar H. Mechanism of photodynamic therapy-induced cell death. Methods Enzymol. 319 (2000) 342-358
36. Harrison D.G., and Bates J.N. The nitrovasodilators. New ideas about old drugs. Circulation 87 (1993) 1461-1467
37. Bates J.N., Baker M.T., Guerra Jr. R., and Harrison D.G. Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochem. Pharmacol. 42 (1991) S157-S165
38. Homer K.L., and Wanstall J.C. Cyclic GMP-independent relaxation of rat pulmonary artery by spermine NONOate, a diazeniumdiolate nitric oxide donor. Br. J. Pharmacol. 131 (2000) 673-682